Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Erna, Motsch"'
Autor:
Rudolf, Kaaks, Evangelia, Christodoulou, Erna, Motsch, Verena, Katzke, Mark O, Wielpütz, Hans-Ulrich, Kauczor, Claus Peter, Heussel, Monika, Eichinger, Stefan, Delorme
Publikováno v:
Translational Lung Cancer Research. 11:1896-1911
Lung cancer screening may provide a favorable opportunity for a spirometry examination, to diagnose participants with undiagnosed lung function impairments, or to improve targeting of computed tomography (CT) screening intensity in view of expected n
Publikováno v:
Translational Lung Cancer Research. 10:233-242
Background Tumor-associated autoantibodies are considered promising markers for early lung cancer detection; so far, however, their capacity to detect cancer has been tested mostly in a clinical context, but not in population screening settings. This
Autor:
Stefan Delorme, Erna Motsch, Sandra González Maldonado, Sylke Ruth Zeissig, Rudolf Kaaks, Claus Peter Heussel, Silke Hermann, Hans-Ulrich Kauczor, Anke Trotter
Publikováno v:
International Journal of Cancer. 148:1097-1105
Overdiagnosis is a major potential harm of lung cancer screening; knowing its potential magnitude helps to optimize screening eligibility criteria. The German Lung Screening Intervention Trial ("LUSI") is a randomized trial among 4052 long-term smoke
Autor:
Stefan Delorme, Rudolf Kaaks, Hans-Ulrich Kauczor, Sandra González Maldonado, Lucas Cory Hynes, Erna Motsch, Hilary A. Robbins, Claus Peter Heussel
Publikováno v:
Transl Lung Cancer Res
Background Current guidelines for lung cancer screening via low-dose computed tomography recommend annual screening for all candidates meeting basic eligibility criteria. However, lung cancer risk of eligible screening participants can vary widely, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b6a3de14eb242f8d03b3cc29aa620d7
https://europepmc.org/articles/PMC8044498/
https://europepmc.org/articles/PMC8044498/
Publikováno v:
Transl Lung Cancer Res
BACKGROUND: Tumor-associated autoantibodies are considered promising markers for early lung cancer detection; so far, however, their capacity to detect cancer has been tested mostly in a clinical context, but not in population screening settings. Thi
Autor:
Anika Hüsing, Erna Motsch, Sandra González Maldonado, Rudolf Kaaks, Stefan Delorme, Claus-Peter Heussel, Hans-Ulrich Kauczor
Publikováno v:
JAMA network open. 3(2)
Malignancy prediction models based on participant-related characteristics and imaging parameters from low-dose computed tomography (CT) may improve decision-making regarding nodule management and diagnosis in lung cancer screening.To externally valid
Autor:
Sandra González Maldonado, Erna Motsch, Stefan Delorme, Rudolf Kaaks, Philipp A. Schnabel, Hans-Ulrich Kauczor, Anthony B. Miller, Anke Trotter, Claus P. Heussel, Nikolaus Becker, Hendrik Dienemann
Publikováno v:
International journal of cancerReferences. 146(6)
In 2011, the U.S. National Lung Cancer Screening Trial (NLST) reported a 20% reduction of lung cancer mortality after regular screening by low-dose computed tomography (LDCT), as compared to X-ray screening. The introduction of lung cancer screening
Autor:
Jan Tremper, Torben Buschulte, Erna Motsch, Mila Trauth, Monika Eichinger, Stefan Delorme, Bertram Jobst, Anke Trotter, Hans-Ulrich Kauczor, Marie-Luise Groß, Nikolaus Becker, Oliver Weinheimer, Mark O. Wielpütz
Publikováno v:
European radiology. 29(6)
To longitudinally investigate smoking cessation-related changes of quantitative computed tomography (QCT)–based airway metrics in a group of heavy smokers. CT scans were acquired in a lung cancer screening population over 4 years at 12-month interv
Autor:
M.-L. Gross, Philipp A. Schnabel, Hans U. Kauczor, D.-E. Optazaite, A. Eigentopf, Claus P. Heussel, H. Dienemann, Michael Puderbach, Natalia Becker, Jan Tremper, Stefan Delorme, Monika Eichinger, Erna Motsch, Mark O. Wielpütz
Publikováno v:
Journal of Thoracic Oncology. 10(6):890-896
Introduction The German Lung Cancer Screening Intervention Trial (LUSI) is one of the European randomized trials investigating the efficacy of low-dose multislice computed tomography (MSCT) as a screening tool for lung cancer. In the evaluation of th
Autor:
Oliver Weinheimer, Bertram J. Jobst, Marie-Luise Groß, Mark O. Wielpütz, Mila Trauth, Jan Tremper, Anke Eigentopf, Nikolaus Becker, Stefan Delorme, Hans-Ulrich Kauczor, Monika Eichinger, Erna Motsch
Publikováno v:
European radiology. 28(2)
To longitudinally evaluate effects of smoking cessation on quantitative CT in a lung cancer screening cohort of heavy smokers over 4 years. After 4 years, low-dose chest CT was available for 314 long-term ex-smokers (ES), 404 continuous smokers (CS)